Subclinical hepatic encephalopathy

Seminars in Liver Disease

Volumn 16, Issue 3, 1996, Pages 321-328

  Quero, J Carlos ^a   Schalm, Solko W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; LACTITOL; LACTULOSE; PLACEBO;

BRAIN ELECTROPHYSIOLOGY; CLINICAL TRIAL; DIET THERAPY; ELECTROENCEPHALOGRAPHY; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW;

EID: 0030451813     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007244     Document Type: Review

References (51)

1. Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S: The electroencephalograph in liver disease. Lancet 2:867-71, 1957.
2. Gitlin N: Subclinical portal-systemic encephalopathy. Am J Gastroenterol 82:8-11, 1988.
3. Zeegen R, Drinkwater JE, Dawson AM: Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 2:633-6, 1970.
4. Rikkers L, Jenko P, Rudman D, Freides D: Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75:462-9, 1978.
5. Gilberstadt SJ, Gilberstadt H, Zieve L, et al: Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 140:519-21, 1980.
6. Marchesini G, Zoli M, Dondi C, et al: Prevalence of Subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid balance. Dig Dis Sci 25:763-8, 1980.
7. Loguercio C, Del Vechio-Blanco C, Coltorti M: Psychometric tests and latent portal-systemic encephalopathy. Br J Clin Pract 38:407-11, 1984.
8. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, non-shunted patients with cirrhosis. J Hepatol 3:75-82, 1986.
9. Joelsson B, Aslund U, Hultberg B, et al: Portal-systemic encephalopathy. Influence of shunt surgery and relations to serum amino acids. Scand J Gastroenterol 21:900-6, 1986.
10. Moore JW, Dunk AA, Crawford JR, et al: Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. J Hepatol 9:319-25, 1989.
11. Sood GK, Sarin SK, Mahaptra J, Broor SL: Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol 2:156-9, 1989.
12. Koch H, Schauder P, Schäfer G, et al: Untersuchungen zur diagnose und prävalenz der latenten hepatischen encephalopathie. Z Gastroenterol 28:610-5, 1990.
13. Schomerus H, Schreiegg J: Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Z Gastroenterol 31:231-4, 1993.
14. Kardel T, Lund Y, Zander Olsen P, et al: Encephalopathy and portocaval anastomosis. Scand J Gastroenterol 5:681-5, 1970.
15. Schomerus H, Hamster W, Blunck H, et al: Latent portasystemic encephalopathy. I. Nature of cerebral function defects and their effect on fitness to drive. Dig Dis Sci 26:622-30, 1981.
16. Tarter RE, Hegedus AM, van Thiel DH, et al: Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology 86:1421-7, 1984.
17. McClain CJ, Potter TJ, Kromhout JP, Zieve L: The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy. J Clin Gastroenterol 6:325-9, 1984.
18. Morgan MY, Alonso M, Stanger LC: Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. J Hepatol 8:208-17, 1989.
19. Salerno F, Moser P, Maggi A, et al: Effects of long-term administration of low-dose lactitol in patients with cirrhosis but without overt encephalopathy. J Hepatol 21:1092-6, 1994.
20. De Bruijn KM, Blendis LM, Zilm DH, et al: Effect of dietary protein manipulations in subclinical portal-systemic encephalopathy. Gut 24:53-60, 1983.
21. Egberts EH, Schomerus H, Hamster W, Jürgens P: Branched chain amino acids in the treatment of latent portosystemic encephalopathy. Gastroenterology 88:887-95, 1985.
22. Plauth M, Egberts EH, Hamster W, et al: Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled crossover study. J Hepatol 17:308-14, 1993.
23. Conn HO: Subclinical hepatic encephalopathy. In Conn HO, Bircher J (eds): Hepatic encephalopathy: Syndromes and therapies. Bloomington, Illinois, Medi-Ed Press, 1994, pp 27-39.
24. Reitan RM: Validity of the trail making test as an indication of organic brain damage. Percept Mot Skills 8:271-6, 1958.
25. Sarin SK, Nundy S: Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver 5:142-6, 1985.
26. Levy LJ, Bolton RP, Losowsky MS: The use of the visual evoked potential (VEP) in delineating a state of subclinical hepatic encephalopathy. A comparison with the number connection test. J Hepatol 5:211-7, 1987.
27. Yen CL, Liaw YF: Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterol 37:332-4, 1990.
28. Weissenborn K, Scholz M, Hinrichs H, et al: Neurophysiological assessment of early hepatic encephalopathy. Electroenceph Clin Neurophysiol 75:289-95, 1990.
29. Hartmann IJC, Quero JC, Schalm SW: Diagnosis of subclinical hepatic encephalopathy: spectral-EEG versus standard psychometric tests. Gastroenterology 108:A1080, 1995.
30. Davies ADM: The influence of age on Trail Making Test performance. J Clin Psychology 24:96-8, 1968.
31. Zeneroli ML, Cioni G, Ventura P, et al: Interindividual variability of the number connection test. J Hepatol 15:263-4, 1992.
32. Conn HO, Leevy CM, Vlahcevic ZR, et al: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72:573-83, 1977.
33. Hamster W, Kluck M, Schomerus H: PSE-Syndrom-Test Kurzform. Beltz Test Gesellschaft, Weinheim. 1985.
34. Dhiman RK, Saraswat VA, Verma M, Naik SR: Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol 10:14-23, 1995.
35. Conn HO: Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 22:541-50, 1977.
36. Zeneroli ML, Pinelli G, Gollini G, et al: Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Gut 25:291-9, 1984.
37. Mehndirrata MM, Sood GK, Sarin SK, Gupta M: Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 85:799-803,1990.
38. Sandford SL, Tarter RE, Sclabassi R, Van Thiel DH: Sensory information processing in patients with nonalcoholic cirrhosis. Short-latency visual, auditory, and somatosensory event-related potentials. J Neurol Sci 80:269-76, 1987.
39. Johansson U, Andersson T, Persson A, Eriksson LS: Visual evoked potential - a tool in the diagnosis of hepatic encephalopathy? J Hepatol 9:227-33, 1989.
40. Davies MG, Rowan MJ, Feely J: Flash visual evoked responses in the early encephalopathy of chronic liver disease. Scand J Gastroenterol 25:1205-14, 1990.
41. Davies MG, Rowan MJ, MacMathuna P, et al: The auditory P300 event-related potential: an objective marker of the encephalopathy of chronic liver disease. Hepatology 12:688-94, 1990.
42. Kugler CF, Lotterer E, Petter J, et al: Visual event-related P300 potentials in early portosystemic encephalopathy. Gastroenterology 103:302-10, 1992.
43. Kullman F, Hollerbach S, Holstege A. Scholmerich J: Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 22:101-10, 1995.
44. Van der Rijt CCD, Schalm SW, de Groot GH, de Vlieger M: Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroenceph Clin Neurophysiol 57:423-6, 1984.
45. O'Neill D: Physicians, elderly drivers and dementia. Lancet 41-3, 1992.
46. Srivastava A, Mehta R, Rothke SP, et al: Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance. J Hepatol 21:1023-8, 1994.
47. Quero JC, De Bruijn I. Hartmann IJC, Schalm SW: Does subclinical hepatic encephalopathy affect quality of life? Gastroenterology 108:A1151, 1995.
48. Kono I, Ueda Y, Yakajima K, et al: Subcortical impairment in subclinical hepatic encephalopathy. J Neurol Sci 126:162-7, 1994.
49. Sackett DL, Haynes RB, Guyatt GH, Tugwell P: The selection of diagnostic tests. In Sacket et al: Clinical epidemiology, a basic science for clinical medicine. Boston, Little, Brown and Company. USA 1991.
50. Tarter RE, Sandford SL, Hays AL, Carra JP: Hepatic injury correlates with neuropsychologic impairment. Intern J Neurosci 44:75-82, 1989.
51. Pérez-Cuadrado Mart́inez E, Silva González C, Robles Reyes A: Variabilidad y alargamiento del tiempo de reacción en el diagnóstico precoz de la encefalopatía hepática subclínica. Rev Esp Enf Digest 77:29-32, 1990.